Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma

BACKGROUND: Current guidelines lack recommendations for the use of immunotherapy and immune-related biomarkers for hepatocellular carcinoma (HCC). We aim to provide reliable evidence of the association of survival with HCC immunotherapy and to demonstrate that genomic mutation signature could be an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Ou, Qiyun, Yu, Yunfang, Li, Anlin, Chen, Jie, Yu, Tingting, Xu, Xiaolin, Xie, Xinxin, Chen, Yongjian, Lin, Dagui, Zeng, Qiaohong, Zhang, Yuxin, Tang, Xudong, Yao, Herui, Luo, Baoming
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154492/
https://ncbi.nlm.nih.gov/pubmed/32309377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.01.32
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars